Evaluating comorbidity scores based on health service expenditures.

Medicare & medicaid research review Pub Date : 2012-10-03 eCollection Date: 2012-01-01 DOI:10.5600/mmrr.002.03.a05
Meredith L Kilgore, Wilson Smith, Jeffrey R Curtis, Michael A Morrisey, David J Becker, Kenneth G Saag, Elizabeth Delzell
{"title":"Evaluating comorbidity scores based on health service expenditures.","authors":"Meredith L Kilgore,&nbsp;Wilson Smith,&nbsp;Jeffrey R Curtis,&nbsp;Michael A Morrisey,&nbsp;David J Becker,&nbsp;Kenneth G Saag,&nbsp;Elizabeth Delzell","doi":"10.5600/mmrr.002.03.a05","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To describe the performance of Charlson Comorbidity Index (CCI) specifications among Medicare beneficiaries and subgroups.</p><p><strong>Data sources: </strong>Medicare data for beneficiaries covered by Parts A and B and not Medicare Advantage throughout 2007.</p><p><strong>Study design: </strong>We evaluated several CCI specifications, particularly a model using expenditures related to Charlson categories, to predict 1 year mortality.</p><p><strong>Data collection/extraction methods: </strong>Data were obtained from the Chronic Condition Data Warehouse.</p><p><strong>Principal findings: </strong>The use of Charlson related expenditures did not result in improved mortality prediction. CCI models perform less well in population subgroups with higher underlying mortality risks based on age and chronic conditions.</p><p><strong>Conclusions: </strong>Relatively simple models provide quite adequate discrimination compared to more sophisticated models. Our proposed and more sophisticated model, which added in expenditure information, did not perform as well as much more easily executed methods.</p>","PeriodicalId":89601,"journal":{"name":"Medicare & medicaid research review","volume":"2 3","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2012-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4006378/pdf/mmrr2012-002-03-a05.pdf","citationCount":"4","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medicare & medicaid research review","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5600/mmrr.002.03.a05","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2012/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 4

Abstract

Objective: To describe the performance of Charlson Comorbidity Index (CCI) specifications among Medicare beneficiaries and subgroups.

Data sources: Medicare data for beneficiaries covered by Parts A and B and not Medicare Advantage throughout 2007.

Study design: We evaluated several CCI specifications, particularly a model using expenditures related to Charlson categories, to predict 1 year mortality.

Data collection/extraction methods: Data were obtained from the Chronic Condition Data Warehouse.

Principal findings: The use of Charlson related expenditures did not result in improved mortality prediction. CCI models perform less well in population subgroups with higher underlying mortality risks based on age and chronic conditions.

Conclusions: Relatively simple models provide quite adequate discrimination compared to more sophisticated models. Our proposed and more sophisticated model, which added in expenditure information, did not perform as well as much more easily executed methods.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
基于卫生服务支出评估共病评分。
目的:描述Charlson合并症指数(CCI)规范在医疗保险受益人和亚组中的表现。数据来源:2007年A和B部分受益人的医疗保险数据,而不是医疗保险优势。研究设计:我们评估了几种CCI规格,特别是使用与Charlson分类相关的支出的模型,以预测1年死亡率。数据收集/提取方法:数据来自慢性病数据仓库。主要发现:使用与Charlson相关的支出并没有导致死亡率预测的改善。CCI模型在基于年龄和慢性病的潜在死亡风险较高的人群亚组中表现不佳。结论:相对简单的模型与更复杂的模型相比,提供了相当充分的判别。我们提出的更复杂的模型,增加了支出信息,不如更容易执行的方法执行得好。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Monitoring and reporting hospital-acquired conditions: a federalist approach. Corrigendum. Trends in complicated newborn hospital stays & costs, 2002-2009: implications for the future. Effect of erythropoiesis-stimulating agent policy decisions on off-label use in myelodysplastic syndromes. Beneficiary activation in the Medicare population.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1